CREST-2 | SOLACI

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Dr. Juan Manuel Pérez - 9 December, 2025 0

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

Dr. Juan Manuel Pérez - 9 December, 2025 0

Atrial septal defect (ASD) is a common congenital heart disease that generates a left-to-right shunt, leading to right-side chamber overload and a risk of...

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Dr. Juan Manuel Pérez - 9 December, 2025 0

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: CREST-2

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Últimas Noticias

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Cardiac Remodeling After Percutaneous ASD Closure: Should It Be Immediate or Progressive?

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos